MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2024 International Congress

    18F-Florzolotau Positron Emission Tomography Imaging Correlates with Regional Brain Atrophy and Plasma Biomarkers in Tauopathy Parkinsonism Syndrome

    CH. Li, SP. Fan, MC. Shih, YH. Weng, TF. Chen, IT. Hsiao, KJ. Lin, CH. Lin (Hsinchu, Taiwan)

    Objective: We aim to investigate the relationship between regional 18F-florzolotau uptake and clinical severity, structural volume changes, and plasma markers in tauopathy parkinsonism syndrome. Background:…
  • 2024 International Congress

    Exploring the Root of Cognitive Decline in People Living with Parkinson’s Disease: An Analysis of MoCA Scores, Neuropsychiatric Symptoms, and Patient-Reported Outcomes

    K. Sánchez-Ramírez, S. Arechavala-Lopez, D. Romero-Terán, A. Hernández-Medrano, M. Medina-Pérez, A. Cervantes-Arriaga, M. Rodríguez-Violante (CULIACAN, Mexico)

    Objective: To evaluate cognitive decline in people living with PD (PwP), to determine to which degree different neuropsychiatric symptoms are risk factors for cognitive decline…
  • 2024 International Congress

    Modeling the Role of Parkinson’s Disease-Specific Factors in Depression and Anxiety: Findings from MEX-PD Cohort

    P. Reyes-Pérez, D. Martínez, I. Estrada-Bellmann, C. Guerra-Galicia, N. Gandarilla-Martínez, E. Morelos Figaredo, K. Salinas-Barboza, Y. Matuk-Pérez, A. Lazaro-Figueroa, M. Rentería, S. Alcauter-Solorzano, A. Ruiz-Contreras, A. Medina-Rivera (Queretaro, Mexico)

    Objective: This study, conducted within the Mexican Parkinson’s Disease Research Network (MEX-PD), aims to explore whether depression and anxiety in PD patients primarily stem from…
  • 2024 International Congress

    Obsessive-Compulsive Disorder Prevalence in Parkinson’s Disease Caregivers

    F. Hojjatipour, M. Salari (tehran, Islamic Republic of Iran)

    Objective: Our goal is to assess the prevalence of obsessive-compulsive disorder (OCD) among those who provide care for individuals with Parkinson's disease (PD). Additionally, we…
  • 2024 International Congress

    RBD Unmasked: LRRK2 and the Prodromal Path to Parkinson’s Disease

    M. Acharya, S. Datta, N. Ghosh, B. Chakraborty (Kharagpur, India)

    Objective: The primary objective is to analyze and compare the prevalence of RBD in LRRK2-positive individuals across different stages, including healthy controls (HC), prodromal Parkinson's…
  • 2024 International Congress

    Comparison of Gastrointestinal Dysfunction in Early-onset and Late-onset Parkinson’s Disease

    C. Arora, N. Kamble, V. Holla, R. Mahale, R. Yadav, P. Pal (BENGALURU, India)

    Objective: To compare the gastrointestinal dysfunction in patients with early-onset Parkinson’s disease (EOPD) and late-onset Parkinson’s disease (LOPD). Background: Gastrointestinal dysfunction is one of the…
  • 2024 International Congress

    Gastrointestinal Dysbiosis and Clinical Outcomes in Parkinson’s Disease

    K. Julio, A. Vakhtin, H. Lin, A. Birg, N. Hoffman, S. Nitschke, N. Shaff, E. Erhardt, A. Mayer, D. Sugar, G. Suarez Cedeno, A. Deligtisch, S. Pirio Richardson, S. Ryman (Albuquerque, USA)

    Objective: To evaluate whether patients with PD exhibit 1) a bloom in sulfate-reducing bacteria based on the detection of hydrogen-sulfide (H2S) during lactulose breath testing…
  • 2024 International Congress

    Autonomic dysfunction and its impact on quality of life in Mexican people living with PD

    MF. Medina Pérez, D. Lopez Galindo, AJ. Hernandez Medrano, DP. Romero Terán, SF. Arechavala Lopez, G. Rivera Monroy, KI. Sanchez Ramirez, A. Abundes Corona, A. Cervantes Arriaga, M. Rodríguez Violante (Mexico, Mexico)

    Objective: To highlight the impact and correlation of autonomic dysfunction in motor symptoms, quality of life and caregiver burden from PwP Background: Autonomic dysfunction (AD)…
  • 2024 International Congress

    Metabolic Progressive Subtypes in Progressive Supranuclear Palsy

    H. Wang (Hangzhou, China)

    Objective: To investigate disease-specific spatiotemporal progression in Progressive supranuclear palsy (PSP) patients using 18F-fluorodeoxyglucose (FDG) PET and the Subtype and Stage Inference (SuStaIn) algorithm, to…
  • 2024 International Congress

    Frequency of Falls as a Presenti̇ng Symptom and Its Effect i̇n Prognosi̇s i̇n Progressi̇ve Supranuclear Palsy

    I. Kamacı, B. Marangozoglu Samanci, B. Zorlu Ucuncuoglu, E. Sahin, B. Bilgin, H. Hanağası (Istanbul, Turkey)

    Objective: We aimed to evaluate frequency of falls as a presenting symptom and its effect on prognosis in PSP patients. Background: Progressive supranuclear palsy is…
  • « Previous Page
  • 1
  • …
  • 36
  • 37
  • 38
  • 39
  • 40
  • …
  • 1554
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Life expectancy with and without Parkinson’s disease in the general population
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Restless Leg Syndrome After Propranolol Intake: A Single Case
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley